0001209191-20-020355.txt : 20200319 0001209191-20-020355.hdr.sgml : 20200319 20200319200015 ACCESSION NUMBER: 0001209191-20-020355 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200317 FILED AS OF DATE: 20200319 DATE AS OF CHANGE: 20200319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Enyedy Mark J CENTRAL INDEX KEY: 0001586965 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 20729931 MAIL ADDRESS: STREET 1: C/O FATE THERAPEUTICS, INC. STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-245-0399 MAIL ADDRESS: STREET 1: 99 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-17 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001586965 Enyedy Mark J 99 ERIE STREET SUITE B CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 5.34 2020-03-17 4 A 0 20000 0.00 A 2030-03-17 Common Stock 20000 20000 D The option becomes exercisable in equal installments on each of the first three anniversaries of the grant date, March 17, 2020. /s/ Jonathan Quick, as Attorney-in-Fact 2020-03-19